Other Affiliated Sites
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
A-Share Information
H-Share Information
2023.05.23
POLL RESULTS OF THE 2022 ANNUAL GENERAL MEETING HELD ON MAY 22, 2023
2023.05.23
ag真人平台官方：关于选举职工代表监事的公告
2023.05.23
ag真人平台官方：关于聘任董事会秘书和证券事务代表的公告
2023.05.23
ag真人平台官方：第六届监事会第一次会议决议公告
2023.05.23
ag真人平台官方：第六届董事会第一次会议决议公告
2023.05.23
ag真人平台官方：2022年年度股东大会决议公告
2023.05.23
ag真人平台官方：2022年年度股东大会法律意见书
2023.04.28
ag真人平台官方：2023年第一季度报告
2023.04.28
2023 FIRST QUARTERLY REPORT
2023.04.19
PROXY FORM FOR THE 2022 ANNUAL GENERAL MEETING
第一页
上一页
10
11
12
13
14
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright © 2024 Hepalink Group. All Rights Reserved.
